---
input_text: 'The study of Wilson disease in pregnancy management. INTRODUCTION: Pregnancy
  management in women with Wilson disease (WD) remains an important clinical problem.
  This research was conducted to investigate how to avoid worsening of WD symptoms
  during pregnancy and increase pregnancy success in women with WD by identifying
  the best pregnancy management approaches in these patients. PATIENTS AND METHODS:
  The clinical data of 117 pregnancies among 75 women with WD were retrospectively
  analyzed. Related information of the fetus was also recorded and analyzed. At the
  same time, regression analysis was performed for data of 22 pregnant women without
  WD, as normal controls. RESULTS: Of a total of 117 pregnancies among the 75 women
  with WD and 31 pregnancies among the 22 control womenincluded in this study, there
  were 108 successful pregnancies and 9 spontaneous abortions. Among the 108 successful
  pregnancies, 97 women a history of copper chelation therapy before pregnancy; all
  97 women stopped anti-copper therapy during pregnancy. The nine women with spontaneous
  abortion had no pre-pregnancy history of copper displacement therapy. The incidence
  of lower limb edema was higher in the WD group than in normal controls (P = 0.036).
  Compared with the control group, there was a higher proportion in the WD group of
  male infants (P = 0.022) and lower average infant birth weight (t = 3.514, P = 0.001).
  CONCLUSION: It is relatively safe for women with WD patients to become pregnant.
  The best management method for pregnancy in women with WD may be intensive pre-pregnancy
  copper chelation therapy and no anti-copper treatment during pregnancy.'
raw_completion_output: |-
  primary_disease: Wilson disease (WD)

  medical_actions: copper chelation therapy; stopping anti-copper therapy during pregnancy

  symptoms: worsening of WD symptoms; lower limb edema; spontaneous abortion

  chemicals: anti-copper therapy

  action_annotation_relationships: copper chelation therapy TREATS worsening of WD symptoms IN Wilson disease; stopping anti-copper therapy during pregnancy PREVENTS worsening of WD symptoms IN Wilson disease; copper chelation therapy (with anti-copper therapy) PREVENTS spontaneous abortion IN Wilson disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  copper chelation therapy (with anti-copper therapy) PREVENTS spontaneous abortion IN Wilson disease

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - copper chelation therapy
    - stopping anti-copper therapy during pregnancy
  symptoms:
    - worsening of WD symptoms
    - lower limb edema
    - HP:0005268
  chemicals:
    - anti-copper therapy
  action_annotation_relationships:
    - subject: copper chelation therapy
      predicate: TREATS
      object: worsening of WD symptoms
      qualifier: MONDO:0010200
      subject_extension: copper chelation therapy
      object_extension: worsening of WD symptoms
    - subject: stopping anti-copper therapy during pregnancy
      predicate: PREVENTS
      object: worsening of WD symptoms
      qualifier: MONDO:0010200
      subject_extension: anti-copper therapy
    - subject: anti-copper therapy
      predicate: PREVENTS
      object: HP:0005268
      qualifier: MONDO:0010200
      subject_extension: copper chelation therapy
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001695
    label: Cardiac arrest
  - id: HP:0001685
    label: Myocardial fibrosis
  - id: HP:0001663
    label: Ventricular fibrillation
  - id: CHEBI:28694
    label: Copper
  - id: CHEBI:18248
    label: Iron
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: HP:0006554
    label: acute liver failure
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0009095
    label: zinc therapy
  - id: MAXO:0001298
    label: therapy
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001399
    label: Hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: HP:0003256
    label: coagulopathy (international normalized ratio >2.0)
  - id: HP:0004445
    label: hepatic encephalopathy (HE)
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: End-stage liver disease
  - id: HP:0100626
    label: End-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0000127
    label: Genetic testing
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000376
    label: liver biopsy
  - id: HP:0001404
    label: hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0001744
    label: Splenomegaly
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: impaired balance
  - id: HP:0001347
    label: hyperreflexia
  - id: HP:0031843
    label: bradyphrenia
  - id: HP:0002362
    label: shuffling gait
  - id: HP:0001621
    label: hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: pramipexole
  - id: CHEBI:2618
    label: amantadine
  - id: HP:0000093
    label: proteinuria
  - id: CHEBI:231592
    label: zinc salts
  - id: MAXO:0000167
    label: antiepileptic therapy
  - id: CHEBI:9168
    label: rapamycin
  - id: CHEBI:55379
    label: cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: HP:0000083
    label: renal failure
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: HP:0001342
    label: intracerebral hemorrhage
  - id: MAXO:0000533
    label: molecular genetic testing
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0001298
    label: Encephalopathy
  - id: MAXO:0009070
    label: SPECT
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:166831
    label: copper chelators
  - id: MAXO:0035064
    label: electron microscopic studies
  - id: MAXO:0000139
    label: autopsy
  - id: HP:0006577
    label: macronodular cirrhosis
  - id: CHEBI:8830
    label: rhodanine
  - id: HP:0001272
    label: Cerebellar Atrophy
  - id: HP:0007263
    label: Spinocerebellar Ataxia
  - id: MAXO:0001610
    label: transcranial magnetic stimulation
  - id: HP:0002015
    label: dysphagia
  - id: HP:0001392
    label: liver disease
  - id: HP:0001396
    label: cholestasis
  - id: HP:0001403
    label: macrovesicular steatosis
  - id: CHEBI:90299
    label: orcein
  - id: MONDO:0000437
    label: Spinocerebellar degeneration
  - id: CHEBI:2948
    label: Azathioprine
  - id: CHEBI:8378
    label: Prednisolone
  - id: HP:0031690
    label: opportunistic infections
  - id: HP:0001397
    label: Steatosis
  - id: HP:0001513
    label: Obesity
  - id: HP:0000819
    label: Diabetes
  - id: HP:6000457
    label: Mallory bodies
  - id: HP:0002829
    label: Arthralgia
  - id: CHEBI:9907
    label: Ursodeoxycholic acid
  - id: MONDO:0007027
    label: Non-alcoholic steatohepatitis (NASH)
  - id: MONDO:0006507
    label: Hereditary hemochromatosis (HH)
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia (AML)
  - id: CHEBI:41977
    label: Daunorubicin
  - id: CHEBI:28680
    label: Cytarabine
  - id: HP:0004808
    label: Acute Myeloid Leukemia (AML)
  - id: CHEBI:16856
    label: Glutathione (GSH)
  - id: CHEBI:53498
    label: Total antioxidant capacity (TAC)
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: HP:0001289
    label: Confusion
  - id: CHEBI:46195
    label: Acetaminophen
  - id: HP:0000989
    label: itchy skin
  - id: CHEBI:63623
    label: dimercaptosuccinic acid
  - id: CHEBI:145810
    label: insulin
  - id: MONDO:0003441
    label: dystonia
  - id: MAXO:0009015
    label: botulinum toxin injection
  - id: MAXO:0000943
    label: deep brain stimulation
  - id: HP:0004305
    label: involuntary movements
  - id: CHEBI:9720
    label: trihexyphenidyl
  - id: CHEBI:35474
    label: minor tranquilizers
  - id: HP:0005268
    label: spontaneous abortion
